Loading chat...
DE SCR47
Concurrent Resolution
Status
5/9/2023
Primary Sponsor
Gerald Hocker
Click for details
AI Summary
-
Proclaims May 2023 as "Cystic Fibrosis Awareness Month" in Delaware
-
Recognizes that cystic fibrosis affects approximately 40,000 children and adults in the United States and over 70,000 worldwide
-
Highlights medical progress: life expectancy for those born 2018-2022 is now predicted to be 56 years, compared to the 1950s when few children lived to attend elementary school
-
Notes FDA approval of Trikafta in 2019, the first triple combination therapy for the most common cystic fibrosis mutation, and lumacaftor/ivacaftor for children ages 12-24 months in 2018
-
Directs that a copy of the resolution be presented to the Cystic Fibrosis Foundation
Legislative Description
Proclaiming May 2023 "cystic Fibrosis Awareness Month" In The State Of Delaware.
Last Action
Passed In House by Voice Vote
5/10/2023